RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Clinical trials for RELAPSED/REFRACTORY AUTOIMMUNE DISEASES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY AUTOIMMUNE DISEASES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests revolutionary CAR-T therapy for incurable autoimmune diseases
Disease control Recruiting nowThis is an early-stage study to test the safety and initial effects of an experimental treatment called LUCAR-G79. It is for adults with severe autoimmune diseases like lupus or scleroderma that have come back or not improved with standard treatments. The treatment involves colle…
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Revolutionary Cancer-Fighting cells turned against the Body's own immune system
Disease control Recruiting nowThis study is testing a treatment called CAR-T cell therapy for people with severe autoimmune diseases like lupus, scleroderma, and inflammatory myositis that have not improved with standard medications. Doctors will collect a patient's own immune cells, modify them in a lab to t…
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: NA • Sponsor: ShenZhen Cell Valley • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First-in-Human trial tests 'Living Drug' for devastating autoimmune conditions
Disease control Recruiting nowThis is a very early study to test the safety and initial effects of a new treatment called LUCAR-DKS1. It is for adults with severe autoimmune diseases like lupus or scleroderma that have come back or not improved with standard treatments. The treatment involves giving patients …
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: EARLY_PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New cell therapy tested for stubborn autoimmune conditions
Disease control Recruiting nowThis early-stage study is testing an experimental injection called AFN50 in adults with severe autoimmune diseases that haven't improved with standard treatments. Researchers will check if the treatment is safe and if it helps control conditions like lupus, myasthenia gravis, and…
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: EARLY_PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC